|Place of Origin:||China|
|Minimum Order Quantity:||100, 000 vials|
|Packaging Details:||one vial/box|
|Payment Terms:||L/C, T/T|
|Supply Ability:||300, 000 vials per day|
|Product:||Medroxyprogesterone Acetate Injection||Specification:||150mg:3ml|
Medroxyprogesterone Acetate Injection Contraceptive Prevention Pregnancy
Product : Medroxyprogesterone Acetate Injection
Specification : 150mg:3ml
Standard : USP
Packing : one vial/box
Medroxyprogesterone Acetate Injectable Suspension, USP contains medroxyprogesterone acetate, a derivative of progesterone, as its active ingredient. Medroxyprogesterone acetate is active by the parenteral and oral routes of administration. It is a white to off-white; odorless crystalline powder that is stable in air and that melts between 200°C and 210°C. It is freely soluble in chloroform, soluble in acetone and dioxane, sparingly soluble in alcohol and methanol, slightly soluble in ether, and insoluble in water.
Medroxyprogesterone Acetate Injectable Suspension, USP for intramuscular (IM) injection is available in vials, each containing 1 mL of medroxyprogesterone acetate sterile aqueous suspension 150 mg/mL.
Indications and Usage :
Medroxyprogesterone Acetate Injectable Suspension, USP is indicated only for the prevention of pregnancy. The loss of bone mineral density (BMD) in women of all ages and the impact on peak bone mass in adolescents should be considered, along with the decrease in BMD that occurs during pregnancy and/or lactation, in the risk/benefit assessment for women who use Medroxyprogesterone Acetate Injectable Suspension, USP long-term.